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Abstract. Symptoms such as ventricular arrhythmias in Brugada syndrome (BS)
typically occur at rest, especially during sleep, suggesting that the autonomic nervous
system (ANS) function may be relevant in the arrhythmogenesis of the disease. The
aim of this work was to assess the ANS response captured by a non-linear heart
rate variability (HRV) measure in 69 patients diagnosed with BS, who underwent
a standardized physical stress test. Heart rate complexity (HRC) was evaluated
by the power-law scaling analysis (β slope) during rest, exercise, recovery and rest
post-recovery, in order to discriminate between symptomatic and asymptomatic BS
patients. Symptomatic patients showed a significant reduction in HRC in comparison
to asymptomatic subjects, after exertion (p=0.015); during the whole recovery period
(p=0.023), and, in particular within the passive recovery phase (p=0.025), as well
as during rest post-recovery (p=0.022). Based on these results, symptoms could
be associated with a lower ANS complexity during the stress test stages where
parasympathetic activity is predominant. Therefore, the proposed HRV indicators
could be of help in the risk stratification of asymptomatic patients.
Keywords: Brugada syndrome, heart rate dynamics, autonomic nervous system, risk
stratification, stress test
1. Introduction
Brugada syndrome (BS) is an inherited disorder characterized by a typical
electrocardiographic pattern presenting a distinct ST-segment elevation in right
precordial leads, associated with a high risk for unexpected sudden cardiac death
(SCD) due to malignant ventricular arrhythmias in absence of any apparent structural
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cardiopathy. Since its description in 1992 as a new cardiac disorder (Brugada &
Brugada 1992), BS has raised a great interest because of its high incidence, especially
in far eastern countries, and its relation to sudden death in young adults and, less
frequently, in infants and children. It has been estimated that BS are responsible for
4-12% of the total amount of SCD and for 20% of SCD in patients without structural
cardiopathy (Brugada, et al. 1998, Antzelevitch, et al. 2005). Although several indicators
have been assessed for the prediction of cardiac events in BS, studies based on the
largest clinical series only proved prior symptoms and spontaneous type-1 Brugada
ECG pattern as consistent predictors of ventricular fibrillation (VF) episodes (Probst,
et al. 2010). Thus, risk stratification in BS still remains controversial, especially
for asymptomatic patients. However, by relating previous symptomatology with the
occurrence of cardiac events in BS, the information provided from new indicators in
symptomatic and asymptomatic patients can be compared and related to the prediction
of VF events.
Since ventricular arrhythmias in BS typically occur at rest and mainly at night,
it is commonly assumed that vagal activity may play a determinant role in the
arrhythmogenesis of this disorder (Matsuo, et al. 1999, Kies, et al. 2004). Indeed,
previous works, focused on the analysis of the autonomic nervous system (ANS) function
using positron emission tomography, have identified sympathetic dysfunctions on BS
patients (Kies et al. 2004, Wichter, et al. 2002, Bigi, et al. 2008, Paul, et al. 2011).
Also, many previous works have studied the autonomic function of BS patients
through HRV analysis (Krittayaphong, et al. 2003, Hermida, et al. 2003, Kostopoulou,
et al. 2010, Nakazawa, et al. 2003, Makimoto, et al. 2010, Tokuyama, et al. 2014, Pierre,
et al. 2007). However, these works are based on linear, time and frequency-domain
methods, being unable to capture the complex, non-linear effects on heart rate (HR)
regulation. We hypothesize that the evaluation of HR dynamics on BS patients through
non-linear fractal methods may provide additional information for risk stratification in
this population.
Moreover, the autonomic response can be better assessed by stimulating the
ANS through controlled maneuvers such as physical exercise. Exertion provokes a
sympathetic activity increase and a parasympathetic inhibition, leading to higher
HR. Conversely, post-exercise cardiodeceleration is adjusted by a continued increase
in parasympathetic activity (Imai, et al. 1994), as well as a progressive sympathetic
withdrawal (Savin, et al. 1982). Since traditional HR analysis at rest commonly fails
to distinguish between symptomatic and asymptomatic BS patients, we explored HR
changes during physical stress testing. Indeed, (Makimoto et al. 2010) published the
first work reporting the interest of exercise to predict ventricular arrhythmias in BS
patients, focusing on recovery after exertion.
Approaches using the power-law scaling exponent (β) obtained from the regression
line of Power Spectral Density (PSD) vs. frequency plot on a bi-logarithmic scale have
shown decreased complexity in patients with cardiovascular disorders and sudden cardiac
death events (Huikuri, et al. 2000, Huikuri, et al. 1998, Lombardi, et al. 2001, Gomis,
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et al. 2006, Maestri, et al. 2007, Tapanainen, et al. 2002). However, we are not aware of
any study that has analyzed the HR dynamics’ complexity (HRC) of symptomatic and
asymptomatic BS patients under conditions of physical activity and recovery.
Thus, the aim of this manuscript was to compare, according to symptomatic status,
the autonomic cardiac control captured by this non-linear complexity indicator from RR
series, in 69 BS patients, for each phase of a standardized physical stress test. The role
of complexity assessment would be helpful in risk stratification of asymptomatic BS
patients for whom the decision to implant an Implantable Cardioverter Defibrillator
(ICD) based on the benefit/risk for the patient is particularly complex.
2. Methods
2.1. Study population
Sixty-nine Brugada syndrome patients underwent a physical exercise stress test while
continuous ECG recordings were acquired. They were enrolled in 6 French centres:
Rennes, Saint Pierre de la Re´union, Nantes, Bordeaux, Brest and La Rochelle. After
approval by the ethics committee of each centre, all participants provided informed
consent to take part in the study, which was performed in accordance with the clinical
research and ethics recommendations. Patients’ age ranged from 19 to 73 years old
(45.06 ± 12.79 years old) and 78.3% were males. Table 1 summarizes participants’
baseline characteristics, where no significant differences in age and gender between
patients included in the symptomatic and asymptomatic groups can be noted. Sixteen
patients had the following documented symptoms: syncope (56.25%), cardiac arrest
(25%), dizziness (18.75%) and, less frequently, palpitations (12.50%) and nocturnal
convulsions (6.25%).
ICD implantation had been performed in 15 of 53 (28.3%) asymptomatic patients,
based on a positive EPS (Electrophysiological Study) test, whereas all symptomatic
patients were ICD carriers. Since no relevant cardiac episodes occurred during the test,
these devices caused no significant effects on the recordings. Among 54 patients (13
were symptomatic) in whom genetic screening was performed, an SCN5A mutation was
found in 19 (35.2%), from whom 5 were symptomatic.
Table 1. Patients’ baseline characteristics.
All patients Symptomatic Asymptomatic p-value
(n=69) (n=16) (n=53)
Age, years old 45.06 ± 12.79 45.88 ± 15.31 44.81 ± 12.09 0.837
Male sex, n (%) 54 (78.3%) 13 (81.3%) 41 (77.4%) 0.743
ICD implantation, n (%) 31 (44.9%) 16 (100%) 15 (28.3%) <0.001
Presence of SCN5A mutation, n (%) 19 (35.2%) 5 (38.5%) 14 (34.2%) 0.656
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2.2. Signal acquisition and test
Patients participated in a clinical protocol recommended by the American Heart
Association (Gibbons, et al. 2002) described as triangular stress test since the load
was increased until it reached the patient’s maximum potential. It was performed on a
cyclo ergometer (Ergoline 900 Egamed, Piestany, Slovakia) and divided in the following
phases:
• Resting phase: supine rest for 8 minutes and rest sitting on the bike for 2 more
minutes.
• Exercise phase:
– Warm-up phase: for men, initial load of 50 watts (W); for women, initial load
of 30 W, both for 2 minutes.
– Incremental exercise phase: for men, initial load of 80 W for 2 minutes and
then incrementing 20 W every 2 minutes; for women, initial load of 50 W
increasing load 20 W every 2 minutes.
• After exercise phase:
– Recovery phase:
∗ Active recovery phase: for men, fixed load of 50 W; for women, fixed load
of 30 W, both for 3 minutes.
∗ Passive recovery phase: total cessation of effort for 3 minutes.
– Rest post-recovery phase: supine rest until reaching 50 minutes of total
recording, never exceeding 30 minutes of resting after recovery.
The purpose of the test was to reach at least 80% of the theoretical maximum heart
rate, defined by the formula MHR = 220− age (Fox & Haskell 1968).
The standard 12-lead ECG recording was collected and analyzed by the central
board (Centre Hospitalier Universitaire de Rennes). It was acquired with the Holter
monitor (ELA medical, Sorin Group, Le Plessis Robinsson, France) and continuously
recorded at rest (from 10 minutes before warm-up phase beginning), during incremental
exercise, recovery (6 minutes) and rest post-recovery. Since each test differed in the
incremental exercise and rest post-recovery periods, the duration for these phases was
fixed to 7 and 10 minutes, respectively, corresponding to the smallest duration found in
the clinical series. Sampling frequency was set at 1000 Hz. Heart rate was continuously
displayed and blood pressure measured with the sphygmomanometric method at rest,
every two minutes during exercise, maximum effort and recovery.
RR series were obtained using a noise-robust wavelet-based algorithm for QRS
complex detection and subsequent R-wave peak location (Dumont, et al. 2010). Since
the result is a non-uniformly sampled RR series, a cubic splines interpolation was applied
to signals in order to obtain regularly sampled data at a rate of 4 Hz.
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Figure 1. Typical RR series obtained from a BS patient during stress test, showing
each phase: (a) resting, (b) warm-up, (c) incremental exercise, (d) active recovery, (e)
passive recovery and (f) rest post-recovery phases.
2.3. Power-law Scaling Analysis
The RR series in healthy subjects fluctuates in a complex way with a non-uniform
pattern that has been associated with fractal behavior and, on a broadband spectrum,
with a 1/f-like distribution (inverse power law). The β index measures the power-
law behavior as the slope of the regression line calculated by the least-squares method
on the linear portion of PSD against frequency plots on a bi-logarithmic scale.
Several studies have employed the frequency band 0.0001-0.01 Hz to analyze long-term
fluctuations when evaluating sudden cardiac death and myocardial infarction (Huikuri
et al. 1998, Tapanainen et al. 2002). However, for short-term recordings, this technique
has also been applied using the 0.003-0.1 Hz band (Lombardi, et al. 2000).
PSD was estimated using the Burg method (Burg 1975) with an optimized order for
each signal, based on the Broersen’s combined information criterion (Broersen 2000), to
obtain the autoregressive model parameters. Since we analyzed short segments of the
RR series, the scaling exponent β was extracted from the frequency band 0.003-0.1 Hz
(-2.5 to -1 on a logarithmic scale).
2.4. Statistical Analysis
Comparisons between symptomatic and asymptomatic patients during different phases
of the test were evaluated by Mann-Whitney U non-parametric tests. The analysis was
made using the commercially available statistical program SPSS 21.0 (IBM, Chicago,
USA) and setting the level of significance at p < 0.05.
Binary logistic regression models were applied to variables that significantly differed
between groups in order to predict the probability of experiencing symptoms, as a
function of HRC measures.
3. Results
Table 2 summarizes the p-values obtained when comparing the β slope analyzed across
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the different phases of the test between symptomatic and asymptomatic BS patients, as
well as the R-squared (R2) as a fitting quality measure between the PSD and its fitted
model associated with each phase. In general, linear models reached an acceptable
goodness of fit, where R2 > 0.86. The lowest fitting qualities were found for exercise
and after recovery phases, which were then analyzed in smaller segments with higher
R2, always greater than 0.92.
Table 2. P-values and R2 obtained when comparing symptomatic and asymptomatic
patients along the test.
β R2
Resting 0.320 0.91
Exercise 0.418 0.86
Warm-up 0.135 0.92
Incremental exercise 0.065 0.94
After exercise 0.015* 0.94
Recovery 0.023* 0.95
Active recovery 0.118 0.96
Passive recovery 0.025* 0.96
Rest post-recovery 0.022* 0.89
*p < 0.05, Mann-Whitney U test.
Figure 2 displays an example of fit for a symptomatic and an asymptomatic patient after
exertion, so as to represent the fitting quality, as well as the β slope decay experienced
by the symptomatic case with respect to the asymptomatic patient.
Figure 2. Linear fit for β extraction after exercise in a symptomatic (left) and in an
asymptomatic (right) BS patient.
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Symptomatic patients showed a significant reduction in HRC, as estimated by
the β slope, in comparison to asymptomatic subjects after exertion (p=0.015); during
recovery (p=0.023), and more specifically during the passive recovery phase (p=0.025),
and at rest post-recovery (p=0.022). Figure 3 reflects how symptomatic patients showed
significantly decreased values in both recovery and post-recovery phases, with respect
to asymptomatic subjects.
Figure 3. Group average results for β during resting, exercise, recovery and post-
recovery phases; for symptomatic and asymptomatic BS patients (*p <0.05).
Table 3 collects the odds ratio (OR), 95% confidence intervals (CI) and p-values
associated with each univariate model applied to variables that significantly differed
between groups.
Table 3. Odds ratios, 95% confidence intervals and p-values associated with significant
HRC indicators in univariate analysis.
Odds Ratio 95% CI p-value
β, recovery 0.180 0.028 - 1.146 0.069
β, passive recovery 0.230 0.029 - 1.812 0.163
β, rest post-recovery 0.097 0.012 - 0.803 0.030*
β, after exercise 0.189 0.036 - 0.992 0.049*
*p < 0.05, Mann-Whitney U test.
During the rest post-recovery phase, β turned to be an independent predictor in
univariate analysis with a 9.7% (p=0.030) decreased risk per one point increase. After
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exercise, β was also a significant predictor of symptoms, decreasing risk by a 18.9% per
each point increase (p=0.049).
Finally, table 4 summarizes the mean ± standard deviation values for symptomatic
and asymptomatic patients and summarizes p-values obtained in each significant case,
showing higher values of HRC for asymptomatic BS patients.
Table 4. Mean ± standard deviation, for symptomatic and asymptomatic patients,
and associated p-values of significant variables.
Symptomatic (n=16) Asymptomatic (n=53) p-value
β, recovery -1.866 ± 0.258 -1.685 ± 0.356 0.023
β, passive recovery -1.773 ± 0.292 -1.655 ± 0.288 0.025
β, rest post-recovery -1.853 ± 0.207 -1.651 ± 0.334 0.022
β, after exercise -1.706 ± 0.335 -1.468 ± 0.423 0.015
4. Discussion
In this study, non-linear HRV indicators were compared in 69 BS subjects who took part
in a standardized physical stress test, in order to discriminate between symptomatic and
asymptomatic patients. Although previous works have already analyzed the autonomic
response of BS patients, this study presents, to our knowledge, the first evaluation of
HR dynamics captured by short-term power-law scaling analysis, under conditions of
physical activity and recovery.
This HRV marker has been employed to assess HRC in other cardiac disorders,
such as chronic heart failure or transient myocardial ischemia, demonstrating decreased
values of complexity in worse cardiac health conditions (Huikuri et al. 2000, Huikuri
et al. 1998, Lombardi et al. 2001, Gomis et al. 2006, Maestri et al. 2007, Tapanainen
et al. 2002).
The results obtained show a significant reduction in β after exertion, during recovery
and rest post-recovery in symptomatic patients, with respect to asymptomatic patients.
Therefore, subjects with higher risk showed lower complexity in HR dynamics, as already
published for other cardiac pathologies.
Those statistically significant variables were then included in univariate logistic
regression models in order to estimate their discrimination power. After recovery, β
turned to be an independent predictor of symptomatology, supporting the idea that
decreased complexity could be related to a greater risk in Brugada syndrome. After
exercise, β was also a significant predictor, relating a decreased power-law scaling
exponent to a worse prognosis.
It should be noted that although other indicators described in the literature assessing
HRV non-linear properties were analyzed, differences between symptomatic and
asymptomatic BS patients were not as significant as those captured by the β slope.
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Despite DFA, the Hurst exponent, Sample Entropy and Higuchi’s Fractal Dimension
capture similar HRV properties (Acharya, et al. 2006, Baumert, et al. 2007), in our
clinical series, only the β slope demonstrated a potential impact on the prediction of
risk in BS patients.
The autonomic nervous system is governed by complex interactions resulting from
feedback loops of non-linear systems, that enable the organism to adapt to abnormal
physiological conditions, such as metabolic variations, stress or disease. According to
previous works, a reduction in the complexity of physiological control systems occurs
with age and disease (Goldberger, et al. 2002, Rabinovich & Abarbanel 1998, Magrans,
et al. 2010). Fractal power-law index β decreased significantly in symptomatic patients
after exertion and recovery, when parasympathetic activity is predominant. Indeed,
(Makimoto et al. 2010) analyzed the parasympathetic reactivation in BS patients by
computing heart rate recovery (HRR) as the heart rate decay in the first minute after
peak exercise cessation, concluding that a higher parasympathetic activity was related to
the occurrence of cardiac events in BS. Thus, recovery stages seem to unmask significant
autonomic differences related to symptomatology, also captured by the non-linear HRV
indicators here presented.
The results found in our work indicate a loss of cardiac rhythm complexity after
exertion and recovery in symptomatic BS patients. This may be explained by the fact
that a decreased organism’s adaptability leads to a reduced complexity of the underlying
biological control systems (Smith, et al. 2005). Moreover, this altered autonomic
cardiac system dynamics when vagal tone is predominant confirms previous works that
highlight the relevant role of autonomic imbalance in the genesis of life-threatening
cardiac arrhythmias in BS (Matsuo et al. 1999, Kies et al. 2004). Indeed, polymorphic
ventricular arrhythmias (PVA) and sudden cardiac death (SCD) mainly occur at rest
and especially during sleep, when parasympathetic activity is predominant.
Data on cardiac ANS analyzed by positron emission tomography has confirmed
that BS patients display some autonomic dysfunction, with increased presynaptic
norepinephrine (NE) recycling and thus a reduction in the concentration of NE at the
synaptic cleft. This imbalance is thought to promote arrhythmogenicity by decreasing
intracellular levels of 3-5-cyclic adenosine monophosphate (cAMP) and thus disrupting
the subsequent signaling pathway with potential implication for arrhythmogenesis
(Wichter et al. 2002, Kies et al. 2004). This may lead to an enlarged transmural
electrical dispersion that results in an increased probability of ventricular arrhythmias.
In addition, the autonomic imbalance might be aggravated with the presence of
physiological downregulation of adrenergic activity, justifying the occurrence of PVA
and SCD at rest or during sleep (Priori, et al. 2000, Yan & Antzelevitch 1999). Other
studies based on the full stomach test demonstrated that vagal stimulation induced by
a large meal not only increased distinctive Brugada-like ECG changes but also lead
to prognostic tendencies, since patients with a positive full stomach test were more
frequently related to life-threatening events than patients with a negative test result
(Miyazaki, et al. 1996, Chalvidan, et al. 2000).
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Thus, findings on the present study further support this hypothesis and provide
additional evidence for the role of autonomic imbalance in the pathophysiology of the
disease. Although we did not find significant differences between groups in metrics
characterizing the parasympathetic component that directly relate the loss of complexity
with an increase in vagal tone, this study highlights the importance of physical stress
testing in order to unmask relevant autonomic changes that could not be captured at
rest, before the test.
Therefore, measurement of HRV not only by conventional but also by new non-
linear methods during physical stress testing could be a helpful tool for documenting
neural regulation alteration related to symptoms, which can have a potential impact on
the progress of risk stratification in BS patients.
However, a relevant limitation of the study is that the clinical value of the analyzed
indicators can only be proved if a close relationship between HRV variations and
ventricular arrhythmias is identified. Here, symptomatic patients had documented
symptoms but since no cardiac events of ventricular origin were induced during the
study; we cannot directly relate HRC alterations in symptomatic patients to a greater
risk for suffering symptoms.
5. Conclusion
We compared non-linear HRV indicators in 69 BS patients who took part in a
standardized physical stress test in order to distinguish between symptomatic and
asymptomatic groups.
Statistically significant differences were found during and after recovery, showing
lower HR dynamics’ complexity in symptomatic patients under conditions of recovery
and rest after recovery.
Although this study is based on a relatively small population of 69 subjects
and, thus, conclusions on symptomatic status predictions cannot be inferred, the
identified differences between symptomatic and asymptomatic BS patients indicate
relevant tendencies of clinical importance. Therefore, significant HRV results could be
of potential help in risk stratification of asymptomatic patients for whom the decision
to implant a cardioverter defibrillator is still contentious.
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